Filtered By:
Source: American Journal of Rhinology and Allergy
Management: Economics

This page shows you your search results in order of date.

Order by Relevance | Date

Total 16 results found since Jan 2013.

Biologics for Nasal Polyps: Synthesizing Current Recommendations into a Practical Clinical Algorithm
CONCLUSIONS: Biologics are emerging as an important option in the management of patients with CRSwNP. While more data is required to fully inform indications, treatment selection, and health economics related to their use, biologics may offer robust symptom relief to patients who have failed other interventions.PMID:36848277 | DOI:10.1177/19458924221147758
Source: American Journal of Rhinology and Allergy - February 27, 2023 Category: ENT & OMF Authors: Neal R Godse Anjeni Keswani Andrew P Lane Stella E Lee Raj Sindwani Source Type: research

Economics of Medical and Surgical Management of Chronic Rhinosinusitis with Nasal Polyps: A Contemporary Review
CONCLUSION: CRSwNP is a chronic condition with high recurrence rates making it a challenge to manage over time. Current research suggests that FESS is more cost-effective than medical management, including use of newer biologics. Further investigation into both direct and indirect costs associated with medical management is warranted to perform accurate cost-effectiveness analyses and allow for the best allocation of limited healthcare resources.PMID:36848274 | DOI:10.1177/19458924221147501
Source: American Journal of Rhinology and Allergy - February 27, 2023 Category: ENT & OMF Authors: Nikita Chapurin Sofia Khan Jorge Gutierrez Zachary M Soler Source Type: research

Biologics for Nasal Polyps: Synthesizing Current Recommendations into a Practical Clinical Algorithm
CONCLUSIONS: Biologics are emerging as an important option in the management of patients with CRSwNP. While more data is required to fully inform indications, treatment selection, and health economics related to their use, biologics may offer robust symptom relief to patients who have failed other interventions.PMID:36848277 | DOI:10.1177/19458924221147758
Source: American Journal of Rhinology and Allergy - February 27, 2023 Category: ENT & OMF Authors: Neal R Godse Anjeni Keswani Andrew P Lane Stella E Lee Raj Sindwani Source Type: research

Economics of Medical and Surgical Management of Chronic Rhinosinusitis with Nasal Polyps: A Contemporary Review
CONCLUSION: CRSwNP is a chronic condition with high recurrence rates making it a challenge to manage over time. Current research suggests that FESS is more cost-effective than medical management, including use of newer biologics. Further investigation into both direct and indirect costs associated with medical management is warranted to perform accurate cost-effectiveness analyses and allow for the best allocation of limited healthcare resources.PMID:36848274 | DOI:10.1177/19458924221147501
Source: American Journal of Rhinology and Allergy - February 27, 2023 Category: ENT & OMF Authors: Nikita Chapurin Sofia Khan Jorge Gutierrez Zachary M Soler Source Type: research

Biologics for Nasal Polyps: Synthesizing Current Recommendations into a Practical Clinical Algorithm
CONCLUSIONS: Biologics are emerging as an important option in the management of patients with CRSwNP. While more data is required to fully inform indications, treatment selection, and health economics related to their use, biologics may offer robust symptom relief to patients who have failed other interventions.PMID:36848277 | DOI:10.1177/19458924221147758
Source: American Journal of Rhinology and Allergy - February 27, 2023 Category: ENT & OMF Authors: Neal R Godse Anjeni Keswani Andrew P Lane Stella E Lee Raj Sindwani Source Type: research

Economics of Medical and Surgical Management of Chronic Rhinosinusitis with Nasal Polyps: A Contemporary Review
CONCLUSION: CRSwNP is a chronic condition with high recurrence rates making it a challenge to manage over time. Current research suggests that FESS is more cost-effective than medical management, including use of newer biologics. Further investigation into both direct and indirect costs associated with medical management is warranted to perform accurate cost-effectiveness analyses and allow for the best allocation of limited healthcare resources.PMID:36848274 | DOI:10.1177/19458924221147501
Source: American Journal of Rhinology and Allergy - February 27, 2023 Category: ENT & OMF Authors: Nikita Chapurin Sofia Khan Jorge Gutierrez Zachary M Soler Source Type: research

Biologics for Nasal Polyps: Synthesizing Current Recommendations into a Practical Clinical Algorithm
CONCLUSIONS: Biologics are emerging as an important option in the management of patients with CRSwNP. While more data is required to fully inform indications, treatment selection, and health economics related to their use, biologics may offer robust symptom relief to patients who have failed other interventions.PMID:36848277 | DOI:10.1177/19458924221147758
Source: American Journal of Rhinology and Allergy - February 27, 2023 Category: ENT & OMF Authors: Neal R Godse Anjeni Keswani Andrew P Lane Stella E Lee Raj Sindwani Source Type: research

Economics of Medical and Surgical Management of Chronic Rhinosinusitis with Nasal Polyps: A Contemporary Review
CONCLUSION: CRSwNP is a chronic condition with high recurrence rates making it a challenge to manage over time. Current research suggests that FESS is more cost-effective than medical management, including use of newer biologics. Further investigation into both direct and indirect costs associated with medical management is warranted to perform accurate cost-effectiveness analyses and allow for the best allocation of limited healthcare resources.PMID:36848274 | DOI:10.1177/19458924221147501
Source: American Journal of Rhinology and Allergy - February 27, 2023 Category: ENT & OMF Authors: Nikita Chapurin Sofia Khan Jorge Gutierrez Zachary M Soler Source Type: research

Biologics for Nasal Polyps: Synthesizing Current Recommendations into a Practical Clinical Algorithm
CONCLUSIONS: Biologics are emerging as an important option in the management of patients with CRSwNP. While more data is required to fully inform indications, treatment selection, and health economics related to their use, biologics may offer robust symptom relief to patients who have failed other interventions.PMID:36848277 | DOI:10.1177/19458924221147758
Source: American Journal of Rhinology and Allergy - February 27, 2023 Category: ENT & OMF Authors: Neal R Godse Anjeni Keswani Andrew P Lane Stella E Lee Raj Sindwani Source Type: research

Economics of Medical and Surgical Management of Chronic Rhinosinusitis with Nasal Polyps: A Contemporary Review
CONCLUSION: CRSwNP is a chronic condition with high recurrence rates making it a challenge to manage over time. Current research suggests that FESS is more cost-effective than medical management, including use of newer biologics. Further investigation into both direct and indirect costs associated with medical management is warranted to perform accurate cost-effectiveness analyses and allow for the best allocation of limited healthcare resources.PMID:36848274 | DOI:10.1177/19458924221147501
Source: American Journal of Rhinology and Allergy - February 27, 2023 Category: ENT & OMF Authors: Nikita Chapurin Sofia Khan Jorge Gutierrez Zachary M Soler Source Type: research

Biologics for Nasal Polyps: Synthesizing Current Recommendations into a Practical Clinical Algorithm
CONCLUSIONS: Biologics are emerging as an important option in the management of patients with CRSwNP. While more data is required to fully inform indications, treatment selection, and health economics related to their use, biologics may offer robust symptom relief to patients who have failed other interventions.PMID:36848277 | DOI:10.1177/19458924221147758
Source: American Journal of Rhinology and Allergy - February 27, 2023 Category: ENT & OMF Authors: Neal R Godse Anjeni Keswani Andrew P Lane Stella E Lee Raj Sindwani Source Type: research

Economics of Medical and Surgical Management of Chronic Rhinosinusitis with Nasal Polyps: A Contemporary Review
CONCLUSION: CRSwNP is a chronic condition with high recurrence rates making it a challenge to manage over time. Current research suggests that FESS is more cost-effective than medical management, including use of newer biologics. Further investigation into both direct and indirect costs associated with medical management is warranted to perform accurate cost-effectiveness analyses and allow for the best allocation of limited healthcare resources.PMID:36848274 | DOI:10.1177/19458924221147501
Source: American Journal of Rhinology and Allergy - February 27, 2023 Category: ENT & OMF Authors: Nikita Chapurin Sofia Khan Jorge Gutierrez Zachary M Soler Source Type: research